Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report)’s share price fell 2.2% during trading on Wednesday . The stock traded as low as $9.79 and last traded at $9.79. Approximately 500 shares changed hands during trading, a decline of 63% from the average daily volume of 1,341 shares. The stock had previously closed at $10.01.
Sumitomo Pharma Stock Performance
The company has a fifty day simple moving average of $8.81 and a two-hundred day simple moving average of $10.39.
Sumitomo Pharma Company Profile
Sumitomo Pharma Co, Ltd., trading OTC under the ticker DNPUF, is a global pharmaceutical company headquartered in Osaka, Japan. It engages in the research, development, manufacturing and marketing of prescription medicines. As part of the broader Sumitomo Group, the company applies integrated drug discovery platforms and collaborative partnerships to bring innovative therapies to market.
The company’s portfolio encompasses central nervous system disorders, oncology, immunology and regenerative medicine.
Further Reading
- Five stocks we like better than Sumitomo Pharma
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
